{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:36:00Z","timestamp":1792784160517,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Joint Council Office","award":["BTD\/13-110157"],"award-info":[{"award-number":["BTD\/13-110157"]}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jcyt.2016.11.009","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T21:06:52Z","timestamp":1482440812000},"page":"419-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Biodegradable poly-\u03b5-caprolactone microcarriers for efficient production of human mesenchymal stromal cells and secreted cytokines in batch and fed-batch bioreactors"],"prefix":"10.1016","volume":"19","author":[{"given":"Alan Tin-Lun","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Pei-Wen","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen Jia-Hui","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen Kuan-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry Kok-Yen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Choolani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaul","family":"Reuveny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Birch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve Kah-Weng","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2016.11.009_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/ten.teb.2015.0004","article-title":"Tissue engineering and regenerative medicine in applied research: a year in review of 2014","volume":"21","author":"Lin","year":"2015","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0015","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cellbi.2006.03.009","article-title":"Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells","volume":"30","author":"Miao","year":"2006","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0020","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1634\/stemcells.2006-0709","article-title":"Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow","volume":"25","author":"Baksh","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0025","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2184.2008.00553.x","article-title":"Human amnion-derived mesenchymal stem cells are a potential source for uterine stem cell therapy","volume":"41","author":"Han","year":"2008","journal-title":"Cell Prolif"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/157488806778226768","article-title":"Human fetal mesenchymal stem cells","volume":"1","author":"O'Donoghue","year":"2006","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12015-012-9418-z","article-title":"The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord","volume":"9","author":"Bongso","year":"2013","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12015-006-0022-y","article-title":"Stem cells in the umbilical cord","volume":"2","author":"Weiss","year":"2006","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12015-010-9165-y","article-title":"Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord","volume":"7","author":"Majore","year":"2011","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0055","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/207326","article-title":"Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential","volume":"2011","author":"Burdon","year":"2011","journal-title":"Bone Marrow Res"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0060","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/stem.269","article-title":"Mesenchymal stromal cells: current understanding and clinical status","volume":"28","author":"Salem","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cyto.2005.11.003","article-title":"Cytokine interactions in mesenchymal stem cells from cord blood","volume":"32","author":"Liu","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0070","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3727\/096368910X550198","article-title":"Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation","volume":"20","author":"Yew","year":"2011","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1189\/jlb.0802397","article-title":"Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice","volume":"73","author":"Lin","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.jcbfm.9600509","article-title":"Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro","volume":"28","author":"Fan","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0085","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/cbin.10294","article-title":"IL-8 enhances the angiogenic potential of human bone marrow mesenchymal stem cells by increasing vascular endothelial growth factor","volume":"38","author":"Hou","year":"2014","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0090","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/130763","article-title":"Mesenchymal stem cells migration homing and tracking","volume":"2013","author":"Sohni","year":"2013","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0095","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1582-4934.2005.tb00379.x","article-title":"Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF)","volume":"9","author":"Byrne","year":"2005","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/scrt442","article-title":"Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly","volume":"5","author":"Amable","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0105","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3181\/0712-RM-356","article-title":"Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue","volume":"233","author":"Rebelatto","year":"2008","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12015-012-9365-8","article-title":"Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential","volume":"9","author":"Al-Nbaheen","year":"2013","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0115","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1089\/ten.tea.2008.0393","article-title":"A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering","volume":"15","author":"Wang","year":"2009","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0120","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jcyt.2016.03.293","article-title":"Expansion in microcarrier-spinner cultures improves the chondrogenic potential of human early mesenchymal stromal cells","volume":"18","author":"Lin","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0125","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jcyt.2016.06.016","article-title":"Biodegradable ECM-Coated PCL Microcarriers Support Scalable Human Early MSC Expansion and in vivo Bone Formation","volume":"18","author":"Shekaran","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0130","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12967-014-0260-8","article-title":"A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods","volume":"12","author":"Madrigal","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/biores.2013.0001","article-title":"Microcarrier culture for efficient expansion and osteogenic differentiation of human fetal mesenchymal stem cells","volume":"2","author":"Goh","year":"2013","journal-title":"Biores Open Access"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0145","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/01.TP.0000159029.48678.93","article-title":"Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta","volume":"79","author":"Le Blanc","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0150","first-page":"16","article-title":"Meeting lot-size challenges of manufacturing adherent cells for therapy","volume":"10","author":"Rowley","year":"2012","journal-title":"Bioprocess Int"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0155","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.biotechadv.2013.03.006","article-title":"Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction","volume":"31","author":"Chen","year":"2013","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0160","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1089\/ten.tec.2011.0255","article-title":"Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions","volume":"17","author":"Santos","year":"2011","journal-title":"Tissue Eng Part C Methods"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1874120700701010038","article-title":"Expansion and Harvesting of hMSC-TERT","volume":"1","author":"Weber","year":"2007","journal-title":"Open Biomed Eng J"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0170","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.theriogenology.2004.05.029","article-title":"Effect of serum concentration, method of trypsinization and fusion\/activation utilizing transfected fetal cells to generate transgenic dairy goats by somatic cell nuclear transfer","volume":"63","author":"Melican","year":"2005","journal-title":"Theriogenology"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0175","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jbiotec.2007.01.005","article-title":"Enhancing cell seeding of scaffolds in tissue engineering through manipulation of hydrodynamic parameters","volume":"129","author":"Bueno","year":"2007","journal-title":"J Biotechnol"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.01.044","article-title":"Poly-epsilon-caprolactone microspheres and nanospheres: an overview","volume":"278","author":"Sinha","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1166\/jnn.2014.9127","article-title":"Scaffold design for bone regeneration","volume":"14","author":"Polo-Corrales","year":"2014","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0190","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2174\/157488812799219018","article-title":"Biodegradable bone regeneration synthetic scaffolds: in tissue engineering","volume":"7","author":"Hammouche","year":"2012","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2011.09.064","article-title":"Poly-e-caprolactone based formulations for drug delivery and tissue engineering: A review","volume":"158","author":"Dash","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/802435","article-title":"In Vitro Degradation of Poly(caprolactone)\/nHA Composites","volume":"2014","author":"D\u00edaz","year":"2014","journal-title":"J Nanomater"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10544-015-0010-6","article-title":"Fabrication of uniform-sized poly-varepsilon-caprolactone microspheres and their applications in human embryonic stem cell culture","volume":"17","author":"Li","year":"2015","journal-title":"Biomed Microdevices"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0210","series-title":"Tunable density and hollow structure of spherical porous poly-\u025b-caprolactone microcarriers for human mesenchymal stem cell growth","author":"Li","year":"2016"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jcyt.2014.08.011","article-title":"Increasing efficiency of human mesenchymal stromal cell culture by optimization of microcarrier concentration and design of medium feed","volume":"17","author":"Chen","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0220","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/scrt498","article-title":"Conjoint propagation and differentiation of human embryonic stem cells to cardiomyocytes in a defined microcarrier spinner culture","volume":"5","author":"Lam","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12896-015-0219-8","article-title":"Enhanced in vitro osteogenic differentiation of human fetal MSCs attached to 3D microcarriers versus harvested from 2D monolayers","volume":"15","author":"Shekaran","year":"2015","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0230","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/430847","article-title":"Wharton's jelly derived mesenchymal stem cells: future of regenerative medicine? Recent findings and clinical significance","volume":"2015","author":"Kalaszczynska","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0235","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/ph8020196","article-title":"Wharton's jelly-derived mesenchymal stromal cells as a promising cellular therapeutic strategy for the management of graft-versus-host disease","volume":"8","author":"McGuirk","year":"2015","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0240","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1089\/ten.teb.2012.0432","article-title":"Microcarriers designed for cell culture and tissue engineering of bone","volume":"19","author":"Park","year":"2013","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jcyt.2014.08.011","article-title":"Increasing efficiency of human mesenchymal stromal cell culture by optimization of microcarrier concentration and design of medium feed","volume":"17","author":"Chen","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0250","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/ten.teb.2013.0537","article-title":"Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications","volume":"20","author":"Sart","year":"2014","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0255","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1089\/ten.teb.2011.0240","article-title":"Biomaterials for the development of peripheral nerve guidance conduits","volume":"18","author":"Nectow","year":"2012","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0260","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1089\/scd.2010.0077","article-title":"Investigations into the metabolism of two-dimensional colony and suspended microcarrier cultures of human embryonic stem cells in serum-free media","volume":"19","author":"Chen","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0265","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s12010-013-0586-3","article-title":"Investigation of growth conditions for the expansion of porcine mesenchymal stem cells on microcarriers in stirred cultures","volume":"172","author":"Ferrari","year":"2014","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0270","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/btpr.1886","article-title":"Growth and functional harvesting of human mesenchymal stromal cells cultured on a microcarrier-based system","volume":"30","author":"Caruso","year":"2014","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0275","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/bit.25281","article-title":"Wegmeyer H. Modulation of mesenchymal stromal cell characteristics by microcarrier culture in bioreactors","volume":"111","author":"Hupfeld","year":"2014","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0280","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4834616","article-title":"Manufacturing of human umbilical cord mesenchymal stromal cells on microcarriers in a dynamic system for clinical use","volume":"2016","author":"Petry","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0285","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/bit.25187","article-title":"A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem\/stromal cells","volume":"111","author":"Dos Santos","year":"2014","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0290","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/term.73","article-title":"Expansion of mesenchymal stem cells using a microcarrier-based cultivation system: growth and metabolism","volume":"2","author":"Schop","year":"2008","journal-title":"J Tissue Eng Regen Med"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0295","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5966\/sctm.2013-0196erratum","article-title":"Concise review: optimizing expansion of bone marrow mesenchymal stem\/stromal cells for clinical applications","volume":"4","author":"Hoch","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0300","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cbpa.2007.05.034","article-title":"Bioreactor development for stem cell expansion and controlled differentiation","volume":"11","author":"King","year":"2007","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0305","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1089\/ten.tea.2008.0345","article-title":"Growth, metabolism, and growth inhibitors of mesenchymal stem cells","volume":"15","author":"Schop","year":"2009","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0310","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/term.224","article-title":"Expansion of human mesenchymal stromal cells on microcarriers: growth and metabolism","volume":"4","author":"Schop","year":"2010","journal-title":"J Tissue Eng Regen Med"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0315","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/jcp.22605","article-title":"The metabolism of human mesenchymal stem cells during proliferation and differentiation","volume":"226","author":"Pattappa","year":"2011","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0320","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/PAT.0b013e32834ab72d","article-title":"Potential therapeutic applications of mesenchymal stromal cells","volume":"43","author":"Larsen","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0325","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2217\/rme.09.74","article-title":"Stem cell paracrine actions and tissue regeneration","volume":"5","author":"Baraniak","year":"2010","journal-title":"Regen Med"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0330","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/ten.teb.2011.0488","article-title":"Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements","volume":"18","author":"Doorn","year":"2012","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0335","doi-asserted-by":"crossref","first-page":"17986","DOI":"10.3390\/ijms140917986","article-title":"Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy","volume":"14","author":"Jin","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0340","doi-asserted-by":"crossref","first-page":"e72604","DOI":"10.1371\/journal.pone.0072604","article-title":"Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis","volume":"8","author":"Hsieh","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0345","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","article-title":"Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease","volume":"33","author":"Bendre","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0350","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.gep.2009.01.001","article-title":"Effect of fluid flow-induced shear stress on human mesenchymal stem cells: differential gene expression of IL1B and MAP3K8 in MAPK signaling","volume":"9","author":"Glossop","year":"2009","journal-title":"Gene Expr Patterns"},{"key":"10.1016\/j.jcyt.2016.11.009_bib0355","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.bbagen.2012.06.007","article-title":"Bioreactors to influence stem cell fate: augmentation of mesenchymal stem cell signaling pathways via dynamic culture systems","volume":"1830","author":"Yeatts","year":"2013","journal-title":"Biochim Biophys Acta"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324916305965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324916305965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:24:02Z","timestamp":1761431042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324916305965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1465324916305965"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2016.11.009","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biodegradable poly-\u03b5-caprolactone microcarriers for efficient production of human mesenchymal stromal cells and secreted cytokines in batch and fed-batch bioreactors","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2016.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}